| Literature DB >> 28451019 |
Adelaide Ogutu Ayoyi1, Gideon Kikuvi2, Christine Bii2, Samuel Kariuki2.
Abstract
INTRODUCTION: Asymptomatic bacteriuria (ASB) is the presence of bacteria in urine without apparent symptoms of urinary tract infections. The importance of asymptomatic bacteriuria lies in the insight it provides into symptomatic infections. To determine prevalence, bacterial isolates and Antibiotic Sensitivity Profile of asymptomatic bacterial urinary tract infection in pregnant women in selected clinics in Nairobi.Entities:
Keywords: Asymptomatic bacteriuria; Kenya; pregnant women
Mesh:
Substances:
Year: 2017 PMID: 28451019 PMCID: PMC5398259 DOI: 10.11604/pamj.2017.26.41.10975
Source DB: PubMed Journal: Pan Afr Med J
Prevalence of asymptomatic bacteriuria
| Bacteriuria | Frequency | Percent | Range at 95%CI |
|---|---|---|---|
| Positive | 219 | 21.5% | 19.1%-23.9% |
| Insignificant | 287 | 28.1% | 25.5%-31.1% |
| Sterile | 321 | 31.5% | 28.6%-34.4% |
| Contamination | 193 | 18.9% | 16.6%-21.4% |
| Total | 1020 | 100.0% | 100.0% |
Distribution of bacteria isolated from positive sample
| Type of bacteria isolates | Frequency | Percent |
|---|---|---|
|
| 85 | 38.8% |
|
| 65 | 29.7% |
|
| 29 | 13.2% |
|
| 17 | 7.8% |
|
| 6 | 2.7% |
|
| 6 | 2.7% |
|
| 5 | 2.3% |
|
| 4 | 1.8% |
|
| 2 | 0.9% |
| Total | 219 | 100.0% |
Logistic regression analysis of association of demographic characteristics with asymptomatic bacteriuria
| Demographic Factors | Asymptomatic Bacteriuria | Sterile | insignificant | Contaminated | OR | P value | (95%CI) |
|---|---|---|---|---|---|---|---|
|
| |||||||
| 15-21 | 73 | 110 | 80 | 67 | |||
| 22-31 | 127 | 188 | 185 | 104 | - | 0.993 | 0.000 |
| 32-45 | 18 | 23 | 22 | 22 | |||
| ˃45 | 1 | 0 | 0 | 0 | |||
|
| |||||||
| Married | 160 | 242 | 140 | 140 | 0.873 | 0.506 | 0.585,1.303 |
| Single | 59 | 79 | 60 | 53 | |||
| 0-1 | 152 | 218 | 172 | 120 | 1.108 | 0.637 | 0.725,1.693 |
| 2-3 | 59 | 89 | 104 | 66 | - | - | - |
| ˃4 | 8 | 14 | 11 | 7 | 0.800 | 0.650 | 0.305,2.099 |
|
| |||||||
| Primary | 82 | 112 | 105 | 72 | 3.140 | 0.313 | 0.340,28.992 |
| Secondary | 45 | 66 | 68 | 42 | 2.822 | 0.363 | 0.301,26.446 |
| College | 57 | 85 | 79 | 47 | 2.851 | 0.357 | 0.307,26.458 |
| University | 1 | 4 | 0 | 1 | - | - | - |
| Non | 34 | 54 | 35 | 31 | 2.705 | 0.385 | 0.286,25.554 |
|
| |||||||
| 0-14 | 18 | 28 | 30 | 19 | 1.086 | 0.836 | 0.497,2.371 |
| 15-28 | 176 | 251 | 219 | 145 | 1.176 | 0.554 | 0.688,2.011 |
| 29-40 | 25 | 42 | 38 | 29 | - | - | - |
| P ≤ 0.05 |
Antibiotic sensitivity pattern of gram negative isolates in asymptomatic bacteriuria
| Antibiotics | E. coli | Proteus Spp | Klebsialla Spp | Pseudomonas Spp | Enterobacter Spp | Citrobacter spp | |
|---|---|---|---|---|---|---|---|
| Ampicillin | R | 77(90.6%) | 6(100%) | 15(88.2%) | 5(83.3%) | 2(100%) | 5(100%) |
| Tetracycline | R | 51(60.0%) | 6(100%) | 12(70.6%) | 6(100%) | 2(100%) | 5(100%) |
| Chloramphenicol | R | 17(17.0%) | 4(66.6%) | 5(29.4%) | 0(0%) | 0(0%) | 2(40.0%) |
| Cotrimoxazole | R | 56(65.9%) | 4(66.7%) | 11(64.7%) | 3(50.0%) | 2(100%) | 4(80.0%) |
| Ciprofloxacin | R | 16(18.8%) | 6(100%) | 4(23.5%) | 0(0%) | 1(50.0%) | 0(0%) |
| Nalidixic acid | R | 36(42.4%) | 1(16.7%) | 4(23.5%) | 0(0%) | 1(50.0%) | 1(20.0%) |
| Ceftazidime | R | 16(18.8%) | 2(33.3%) | 8(47.1%) | 3(50.0%) | 1(50.0%) | 0(0%) |
| Gentamycin | R | 10(11.8%) | 0(0%) | 3(17.6%) | 0(0%) | 0(0%) | 0(0%) |
| Amoxy/clavu | R | 49(57.6%) | 3(50.0%) | 9(52.9%) | 3(50.0%) | 1(50.0%) | 4(80.0%) |
| Cefotaxime | R | 63(74.1%) | 3(50.0%) | 14(82.4%) | 2(33.3%) | 2(100%) | 4(80.0%) |
| Imipenem | R | 0(0%) | 0(0%) | 1(5.9%) | 0(0%) | 0(0%) | 0(0%) |
| Kanamycin | R | 66(77.6%) | 0(0%) | 5(29.4%) | 2(33.3%) | 1(50.0%) | 2(40.0%) |
Antibiotic sensitivity pattern of gram positive isolatesin asymptomatic bacteriuria
| Antibiotics | Staph aureus | Non coagulase staph | Enterococcus | |
|---|---|---|---|---|
| n=65 | n=29 | n=4 | ||
| Ampicillin | R | 60(92.3%) | 22(75.9%) | 2(50.0%) |
| Tetracycline | R | 33(50.7%) | 14(48.3%) | 1(25.0%) |
| Chloramphenicol | R | 21(32.3%) | 6(20.7%) | 0(0%) |
| Cotrimoxazole | R | 37(56.9%) | 22(75.9%) | 3(75.0%) |
| Ciprofloxacin | R | 24(36.9%) | 12(41.4%) | 2(50.0%) |
| Ceftazidime | R | 41(63.1%) | 15(51.7%) | 3(75.0%) |
| Gentamycin | R | 17(26.2%) | 10(34.5%) | 2(50.0%) |
| Amoxy/clavua | R | 37(56.9%) | 12(41.4%) | 2(50.0%) |
| Cefotaxime | R | 61(93.8%) | 25(86.2%) | 3(75.0%) |
| Imipenem | R | 4(6.2%) | 3(10.3%) | 0(0%) |
| Kanamycin | R | 16(24.6%) | 6(20.7%) | 3(75.0%) |